|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.53 SEK | +51.43% |
|
-.--% | -6.03% |
| Mar. 28 | Chosa Oncology Names CFO, Chief Commercial Officer | MT |
| Mar. 28 | CHOSA Oncology AB Announces Chief Financial Officer Changes | CI |
RhoVac AB announced that Peter Buhl Jensen has taken over as the new CEO. Lars Hedbys remains a board member of the Company.
| 1st Jan change | Capi. | |
|---|---|---|
| -6.03% | 3.14M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
CHOSA ONCOLOGY AB 
